Get the Stockscreener App
1.70
2.41%
0.04
After Hours:
1.65
-0.05
-2.94%
Reneo Pharmaceuticals Inc Stock (RPHM) Forecast
The Reneo Pharmaceuticals Inc (RPHM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.7285, representing a +60.50% increase from the current price of $1.70. The highest analyst price target is $2.6277, and the lowest is $2.8293.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RPHM Price Target
Average 2.9986
(+76.39% Upside)
Is Reneo Pharmaceuticals Inc (RPHM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 66.68 | Neutral |
| STOCH(9,6) | 71.45 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0364 | Buy |
| ADX(14) | 18.62 | Neutral |
| William %R | -8.1649 | Sell |
| CCI(14) | 168.46 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.52
Buy
|
1.5472
Buy
|
| MA20 |
1.4635
Buy
|
1.5053
Buy
|
| MA50 |
1.4742
Buy
|
1.5004
Buy
|
| MA100 |
1.5546
Buy
|
1.6353
Buy
|
| MA200 |
1.6292
Buy
|
2.5302
Sell
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, RPHM could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on RPHM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.68 indicates that RPHM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.45 indicates that RPHM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that RPHM is oversold. This suggests that RPHM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.62 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 168.46 indicates that RPHM is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RPHM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reneo Pharmaceuticals Inc financial reports and earnings history, Reneo Pharmaceuticals Inc (RPHM) stock could reach $5.2246 by 2030, $29.06 by 2040 and $60.01 by 2050. See the projected annual prices until 2050 of the Reneo Pharmaceuticals Inc stock below:
- Reneo Pharmaceuticals Inc (RPHM) is expected to reach an average price of $33.29 in 2035, with a high prediction of $32.99 and a low estimate of $33.49. This indicates an $1,858% rise from the last recorded price of $1.70.
- Reneo Pharmaceuticals Inc (RPHM) stock is projected to chart a bullish course in 2040, with an average price target of $28.80, representing an $1,594% surge from its current level. The forecast ranges from a conservative $28.76 to a sky-high $29.06.
- Our analysts predict Reneo Pharmaceuticals Inc (RPHM) to jump 536.83% by 2045, soaring from $10.86 to an average price of $10.83, potentially reaching $11.59. While $10.86 is the low estimate, the potential upside is significant.
- Reneo Pharmaceuticals Inc (RPHM) stock is expected to climb by 2050, reaching an average of $58.64, a $3,350% jump from its current level. However, a wide range of estimates exists, with high and low targets of $60.01 and $58.86, respectively, highlighting the market's uncertainty.
Reneo Pharmaceuticals Inc Stock (RPHM) Year by Year Forecast
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2024
Our forecast for RPHM stock price in 2024 now indicates an average price target of $2.1877 with a high forecast of $3.8755 and a low forecast of $0.50. The average prediction reflects an increase of +28.69% from the last recorded price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $3.1377 | $2.8293 | $2.6277 | +84.57% |
| December, 2024 | $0.6622 | $2.9522 | $2.4499 | -61.05% |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2025
Reneo Pharmaceuticals Inc Stock (RPHM) is expected to reach an average price of $2.9986 in 2025, with a high prediction of $5.5437 and a low estimate of $0.4535. This indicates an +76.39% rise from the last recorded price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.5528 | $1.9083 | $2.3167 | +50.17% |
| February, 2025 | $0.3773 | $0.5312 | $0.9188 | -77.80% |
| March, 2025 | $2.6018 | $0.4535 | $2.5018 | +53.05% |
| April, 2025 | $3.7225 | $3.438 | $3.4525 | +118.97% |
| May, 2025 | $4.927 | $4.4086 | $4.387 | +189.82% |
| June, 2025 | $5.5315 | $5.2491 | $5.1715 | +225.38% |
| July, 2025 | $5.8421 | $5.8476 | $5.5437 | +243.65% |
| August, 2025 | $5.2566 | $5.4766 | $5.4882 | +209.21% |
| September, 2025 | $4.7611 | $4.8011 | $5.1327 | +180.07% |
| October, 2025 | $4.5018 | $4.2056 | $4.2073 | +164.81% |
| November, 2025 | $3.7763 | $3.7301 | $4.2022 | +122.13% |
| December, 2025 | $3.3069 | $2.9236 | $3.2724 | +94.52% |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2026
The predicted value for Reneo Pharmaceuticals Inc (RPHM) in 2026 is set at an average of $3.2877. Estimates vary from a peak of $6.4159 to a trough of $0.1594, indicating an +93.39% surge from the present price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.2114 | $3.5253 | $3.1114 | +88.91% |
| February, 2026 | $3.7873 | $3.2075 | $3.3759 | +122.78% |
| March, 2026 | $4.2104 | $3.9643 | $3.6805 | +147.67% |
| April, 2026 | $3.1411 | $3.2711 | $3.5427 | +84.77% |
| May, 2026 | $2.6156 | $2.9456 | $2.9572 | +53.86% |
| June, 2026 | $2.2701 | $2.397 | $2.3178 | +33.53% |
| July, 2026 | $0.9393 | $0.1594 | $1.6154 | -44.75% |
| August, 2026 | $5.3948 | $0.2633 | $6.4159 | +217.34% |
| September, 2026 | $3.4442 | $2.5425 | $6.2087 | +102.60% |
| October, 2026 | $2.7096 | $2.0258 | $5.0019 | +59.39% |
| November, 2026 | $2.5951 | $1.5885 | $3.5313 | +52.66% |
| December, 2026 | $1.8645 | $1.2245 | $4.4629 | +9.68% |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reneo Pharmaceuticals Inc (RPHM) is $6.159, with a high forecast of $12.29 and a low forecast of $0.0267. This indicates an +262.29% increase from the last price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.47 | $1.8784 | $3.96 | +104.12% |
| February, 2027 | $4.8355 | $3.0239 | $5.0616 | +184.44% |
| March, 2027 | $4.6449 | $3.8295 | $5.8394 | +173.23% |
| April, 2027 | $3.4004 | $2.7765 | $4.7686 | +100.02% |
| May, 2027 | $1.3642 | $1.4042 | $4.982 | -19.76% |
| June, 2027 | $0.8048 | $0.8849 | $0.9703 | -52.66% |
| July, 2027 | $0.5893 | $0.5993 | $0.6909 | -65.34% |
| August, 2027 | $0.3638 | $0.4138 | $0.5254 | -78.60% |
| September, 2027 | $0.0244 | $0.0844 | $0.2999 | -98.56% |
| October, 2027 | $0.1289 | $0.0267 | $0.2311 | -92.42% |
| November, 2027 | $7.3268 | $8.3968 | $9.35 | +330.99% |
| December, 2027 | $9.718 | $12.28 | $12.29 | +471.65% |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2028
In 2028, Reneo Pharmaceuticals Inc (RPHM) is projected to reach an average price of $11.40, with a high projection of $13.37 and a low estimate of $9.4269. This indicates an +570.36% rise from the last price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.00 | $12.20 | $11.59 | +605.71% |
| February, 2028 | $12.67 | $12.63 | $11.84 | +645.06% |
| March, 2028 | $9.2473 | $12.53 | $12.09 | +443.96% |
| April, 2028 | $11.25 | $11.80 | $10.90 | +561.55% |
| May, 2028 | $12.67 | $12.72 | $12.36 | +645.15% |
| June, 2028 | $10.93 | $11.37 | $12.07 | +542.74% |
| July, 2028 | $11.80 | $11.90 | $11.61 | +593.86% |
| August, 2028 | $8.9669 | $9.4269 | $9.5679 | +427.46% |
| September, 2028 | $11.79 | $10.34 | $11.31 | +593.29% |
| October, 2028 | $12.26 | $12.45 | $11.99 | +621.47% |
| November, 2028 | $13.61 | $12.90 | $12.95 | +700.36% |
| December, 2028 | $13.81 | $13.47 | $13.37 | +712.07% |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2029
The 2029 price forecast for Reneo Pharmaceuticals Inc Stock (RPHM) is $10.48 on average, with a high prediction of $13.55 and a low estimate of $7.4224. This represents an +516.76% increase from the previous price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.50 | $13.65 | $13.55 | +693.91% |
| February, 2029 | $13.07 | $13.10 | $13.21 | +668.56% |
| March, 2029 | $11.64 | $12.16 | $12.48 | +584.97% |
| April, 2029 | $11.64 | $11.40 | $11.49 | +584.91% |
| May, 2029 | $10.45 | $10.58 | $11.29 | +514.99% |
| June, 2029 | $9.9638 | $9.6883 | $9.7127 | +486.11% |
| July, 2029 | $9.6528 | $10.02 | $9.5692 | +467.81% |
| August, 2029 | $9.9941 | $9.5951 | $9.7441 | +487.89% |
| September, 2029 | $9.6631 | $10.03 | $9.7563 | +468.42% |
| October, 2029 | $8.9344 | $9.0121 | $9.4454 | +425.55% |
| November, 2029 | $7.9334 | $8.2134 | $8.5116 | +366.67% |
| December, 2029 | $6.3124 | $7.4224 | $7.7356 | +271.32% |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2030
Reneo Pharmaceuticals Inc Stock (RPHM) is expected to reach an average price of $2.627 in 2030, with a high forecast of $5.2246 and a low forecast of $0.0293. This signifies an +54.53% surge from the last price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3737 | $4.7236 | $5.2246 | +157.27% |
| February, 2030 | $0.5027 | $0.7804 | $2.2159 | -70.43% |
| March, 2030 | $1.1117 | $1.3117 | $0.9741 | -34.61% |
| April, 2030 | $1.6307 | $0.7662 | $0.5538 | -4.08% |
| May, 2030 | $0.242 | $1.6675 | $1.247 | -85.77% |
| June, 2030 | $1.991 | $0.1342 | $1.401 | +17.12% |
| July, 2030 | $0.1577 | $0.5623 | $1.0132 | -90.72% |
| August, 2030 | $0.6687 | $0.1145 | $2.4687 | -60.66% |
| September, 2030 | $1.4897 | $0.7965 | $2.0365 | -12.37% |
| October, 2030 | $0.7785 | $0.0293 | $1.6674 | -54.21% |
| November, 2030 | $3.7406 | $0.975 | $3.9683 | +120.03% |
| December, 2030 | $3.2596 | $3.3397 | $3.5228 | +91.74% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):